- Home
- BOLT vs ERNA Comparison
BOLT vs ERNA Comparison
Compare BOLT & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- ERNA
- Stock Information
- Founded
- BOLT 2015
- ERNA 2018
- Country
- BOLT United States
- ERNA United States
- Employees
- BOLT N/A
- ERNA N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- BOLT Health Care
- ERNA Health Care
- Exchange
- BOLT Nasdaq
- ERNA Nasdaq
- Market Cap
- BOLT 16.8M
- ERNA 14.5M
- IPO Year
- BOLT 2021
- ERNA N/A
- Fundamental
- Price
- BOLT $0.37
- ERNA $0.19
- Analyst Decision
- BOLT Hold
- ERNA
- Analyst Count
- BOLT 5
- ERNA 0
- Target Price
- BOLT $1.13
- ERNA N/A
- AVG Volume (30 Days)
- BOLT 145.0K
- ERNA 213.9K
- Earning Date
- BOLT 05-13-2025
- ERNA 05-13-2025
- Dividend Yield
- BOLT N/A
- ERNA N/A
- EPS Growth
- BOLT N/A
- ERNA N/A
- EPS
- BOLT N/A
- ERNA N/A
- Revenue
- BOLT $7,690,000.00
- ERNA $582,000.00
- Revenue This Year
- BOLT N/A
- ERNA N/A
- Revenue Next Year
- BOLT $77.45
- ERNA N/A
- P/E Ratio
- BOLT N/A
- ERNA N/A
- Revenue Growth
- BOLT N/A
- ERNA 755.88
- 52 Week Low
- BOLT $0.30
- ERNA $0.15
- 52 Week High
- BOLT $1.34
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- BOLT 48.52
- ERNA 44.20
- Support Level
- BOLT $0.33
- ERNA $0.17
- Resistance Level
- BOLT $0.39
- ERNA $0.21
- Average True Range (ATR)
- BOLT 0.04
- ERNA 0.02
- MACD
- BOLT 0.00
- ERNA 0.00
- Stochastic Oscillator
- BOLT 66.06
- ERNA 73.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.